Introduction
The endogenous agonists of cannabinoid receptors exhibit multiple biological functions in various tissues, such as neurons, the immune system and the cardiovasculature (Hillard, 2000; Randall et al., 2002) . Among these endocannabinoids, arachidonoylethanolamide (anandamide) recognizes several receptors (Di Marzo et al., 2002) and acts predominantly in the cardiovascular system (Randall and Kendall, 1997; Randall and Kendall, 1998) . Anandamide is produced by vascular endothelial cells (Deutsch et al., 1997; Sugiura et al., 1998 ) that express either the cannabinoid 1 receptor [CB 1 R; CNR1 (Maccarrone et al., 2000) ] or the CB 2 receptor [CB 2 R; CNR2 ], depending on the source and species of the cells. Notably, most of our recent knowledge on the CB receptor type underlying anandamide-induced physiological effects is based on the use of two selective inhibitors of CB 1 R and CB 2 R: rimonabant (SR141716A; N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride) (Rinaldi-Carmona et al., 1994; Showalter et al., 1996) and SR144528 [N-[(1S)-endo-1,3,3-trimethyl bicyclo[2.2.1] heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazo le-3-carboxamide (Griffin et al., 2000; Rinaldi-Carmona et al., 1998; Showalter et al., 1996) ], respectively. Endothelium-dependent relaxation was found to be sensitive to rimonabant (Chaytor et al., 1999; Mukhopadhyay et al., 2002; Wagner et al., 1999 ; White and Hiley, 1997) but not to gap junction inhibitors (Chaytor et al., 1999) and blockade of the vanilloid receptor 1 (Grainger and Boachie-Ansah, 2001; Mukhopadhyay et al., 2002) , another putative receptor of anandamide on endothelial cells. However, in mice that lack CB 1 R and CB 2 R, anandamideinduced mesenteric vasodilation was still prevented by rimonabant (Offertaler et al., 2003) , thus, leading to the concept of an 'atypical' endothelial anandamide receptor (e-aR) that is also sensitive to rimonabant. Hence, this receptor was found to be activated by the cannabinoid analogs abnormal cannabidiol (-)-4-(3-3,4-trans-pmenthadien- [1, 8] -yl)-olivetol) and O1602 [5-methyl-4-[(1R,6R )-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol; an agonist of 'atypical' non-CB 1 /CB 2 endothelial anandamide receptor (Offertaler et al., 2003) , and to be inhibited by O1918 (Offertaler et al., 2003) . The e-aR was shown to be coupled to G i/o protein and to trigger Ca 2+ -activated formation of nitric oxide in endothelial cells (Mukhopadhyay et al., 2002) .
Considering the large amount of recent reports using rimonabant and the variety of vascular effects of anandamide, which include inhibition of endothelin 1 expression (Ronco et al., 2006) , relaxation of mesenteric arteries (Hoi and Hiley, 2006) , or the inhibition of CB 1 R-mediated tumor growth and metastatic spreading (Portella et al., 2003) , endocannabinoid-triggered signaling in endothelial cells needs to be explored in more detail.
Despite the intriguing reports on the existence of e-aR in human endothelial cells, most reports on endothelial cells did not Although the endocannabinoid anandamide is frequently described to act predominantly in the cardiovascular system, the molecular mechanisms of its signaling remained unclear. In human endothelial cells, two receptors for anandamide were found, which were characterized as cannabinoid 1 receptor (CB 1 R; CNR1) and G-protein-coupled receptor 55 (GPR55). Both receptors trigger distinct signaling pathways. It crucially depends on the activation status of integrins which signaling cascade becomes promoted upon anandamide stimulation. Under conditions of inactive integrins, anandamide initiates CB 1 R-derived signaling, including G i -protein-mediated activation of spleen tyrosine kinase (Syk), resulting in NFκB translocation. Furthermore, Syk inhibits phosphoinositide 3-kinase (PI3K) that represents a key protein in the transduction differentiate between the signal transduction triggered by the two receptor types present. Thus, the underlying signal transduction cascades beyond each individual receptor type are still unclear. Moreover, as these receptors are presumably activated by anandamide at the same time, interplay between the two signaling cascades activated by each of these receptors may occur and needs further investigation.
Consequently, in this study we intended to explore the signaling cascades downstream of CB 1 R and e-aR in human endothelial cells. Furthermore, the interrelation and integration of the two signaling pathways on the initiation of cytosolic Ca 2+ signaling as a highly specific readout of activation of e-aR were investigated.
Results
The effect of anandamide on endothelial Ca 2+ signaling inversely depended on external Ca 2+ and was due to atypical endothelial anandamide receptors
In the presence of 2 mM external Ca 2+ , addition of 10 μM anandamide yielded very small cytosolic Ca 2+ elevation in only 10% of the cells, which was far less than that obtained with 100 μM histamine under identical conditions (Fig. 1A) 1B) and, similar to histamine, over 95% of the cells responded to the endocannabinoid while there was no effect upon stimulation with 10 μM arachidonic acid (supplementary material Fig. S1 ). Moreover, consequent to a strong endoplasmic reticulum (ER) depletion by either anandamide or histamine (Fig. 1C) , capacitative Ca 2+ entry was detected upon re-addition of extracellular Ca 2+ (Fig.  1B) . The EC 50 for anandamide to initiate Ca 2+ signaling in nominally Ca 2+ -free solution was 7.3 (4.5-11.7) μM (n=10), which was comparable with that of the metabolically stable analog methanandamide n=10] (Fig. 1D) , thus indicating that anandamide-induced Ca 2+ signaling is directly evoked by the compound itself and not by a metabolite.
To define the receptor being involved in anandamide-triggered endothelial Ca 2+ signaling, the expression of CB 1 R but not CB 2 R was confirmed by RT-PCR in the human endothelial cells used in this study ( Fig. 2A) . Involvement of CB 2 R was further excluded by the lack of the CB 2 R antagonist SR144528 [1 μM (RinaldiCarmona et al., 1998) Fig. S2A ). Similarly, inhibition of TRPV1 (VR1) receptors by SB366791 [4Ј-chloro-3-methoxycinnamanilide (Fowler et al., 2003) ] (10 μM) failed to affect anandamide-induced Ca 2+ signaling under the same conditions (supplementary material Fig. S2B ). By contrast, rimonabant (1 μM), an inhibitor of CB 1 R and e-aR Wagner et al., 1999) , inhibited anandamide-induced Ca 2+ signaling in nominally Ca 2+ -free solution (Fig. 2B) .
To further differentiate whether CB 1 R or e-aR is involved in anandamide-induced Ca 2+ signaling, the effects of specific receptor agonists and antagonists were tested. Inhibition of CB 1 R by 10 μM of the potent (Fig. 2C ). In addition, the synthetic CB 1 R agonist HU-210 [10 μM (Felder et al., 1995) ], which has been shown to couple with intracellular Ca 2+ signaling in HEK 293 cells, cultured hippocampal neurons (Lauckner et al., 2005) and rat insulinoma beta cells (De Petrocellis et al., 2007) , failed to initiate endothelial Ca 2+ signaling in the presence and nominal absence of external Ca 2+ (supplementary material Fig. S2C ). By contract, 10 μM of O1602, an agonist of the e-aR (Table 1) (Bukoski et al., 2002; Jarai et al., 1999 ) evoked a very strong cytosolic Ca 2+ elevation even in the presence of extracellular Ca 2+ (Fig. 2D) , which was not affected by the TRPV1 receptor inhibitor SB366791 (10 μM) (supplementary material Fig. S2D ). In line with these findings, 10 μM of O1918 [1,3-dimethoxy-5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-benzene] (Table 1) , a cannabidiol analog that acts as a selective antagonist of 'atypical' cannabidiol at the non-CB 1 /CB 2 endothelial anandamide receptor Mo et al., 2004; Offertaler et al., 2003) . Cytosolic (A,B,D) and ER (C) Ca 2+ concentrations were recorded using fura-2 and YC4er, respectively. *P<0.01 versus histamine. 2E). Moreover, in the presence of the CB 1 R-specific agonist HU-210 (10 μM), activation of the e-aR with 10 μM O1602 failed to evoke Ca 2+ signaling, while, after washout of HU-210, O1602 initiated Ca 2+ signaling in the same cells (Fig. 2F ). These data point to involvement of both anandamide receptors in endothelial cells in which CB 1 R inhibits the signal cascade beyond e-aR, which yields intracellular Ca 2+ mobilization and becomes overt in the nominal absence of external Ca 2+ .
The ʻatypicalʼ non-CB 1 and CB 2 endothelial anandamide receptor (e-aR) was identified as G-protein-coupled receptor 55 (GPR55)
To identify the e-aR molecularly, the endothelial cells used for this study were tested for GPR55, a putative anandamide-binding protein (Baker et al., 2006; Ryberg et al., 2007) . Using the respective primers, mRNA of GPR55 was found in endothelial cells (Fig. 2G) . Hence, treatment with siRNA against GPR55, which was proved to reduce the expression of GPR55 by ~56% (supplementary material Fig. S2E (Fig. 2J) . Consistent with this, the effect of O1602 (10 μM) on endothelial cytosolic free-Ca 2+ was largely elevated in GPR55-overexpressing cells (Fig. 2K, Table 1 ).
Recently, GPR55 was described as a receptor of lysophosphatidylinositol [LPI (Oka et al., 2007) ]. These data could be confirmed in endothelial cells in which the effect of 10 μM LPI was strongly reduced in cells treated with siRNA against GPR55 (supplementary material Fig. S2G ), whereas overexpression of GPR55 yield enhanced Ca 2+ signaling by LPI (supplementary material Fig. S2H ). (Leitinger et al., 2000) . Therefore, involvement of clustered integrins in the transition of anandamide to evoke Ca 2+ signaling was postulated. To challenge this hypothesis, clustering of integrins was initiated by Mn 2+ , which increases the affinity of integrins for their ligand and can stimulate integrin clustering (Mould et al., 1998; Smith and Cheresh, 1990) (Fig. 3C ). In line with these results, inhibition of RhoA-associated kinase 1 and RhoA-associated kinase 2 (ROCK1 and ROCK2) that are essentially involved in the clustering of integrins (RodriguezFernandez et al., 2001) , by Y27632 [(R)-(+)-trans-N-(4-Pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide] [10 μM (Uehata et al., 1997) ] strongly diminished anandamide-induced Ca 2+ signaling in the absence of extracellular Ca 2+ (Fig. 3D ). Involvement of integrins was further confirmed by the inhibitory activities of fibronectin (20 μg/ml, supplementary material Fig. S3D ), a large extracellular matrix protein ligand for endothelial integrins, and RGD, Arg-Gly-Asp peptide resembling the integrin-binding motif of fibronectin (Ruoslahti and Pierschbacher, 1987) (20 μg/ml; supplementary material Fig. S3E ).
To further challenge the concept that integrins are involved in the process of anandamide-triggered Ca 2+ signaling, the effects (Fig. 2F, suppl. Fig. S2C ) CB 1 R agonist 10 Prevented Ca 2+ signaling upon AEA (Felder et al., 1995; Fischbach et al., 2007 ) O1602 (Fig. 2D,F,K, e-aR/GPR55 agonist 10 Triggered Ca 2+ signaling even in (Bukoski et al., 2002; Jarai et al., 1999 ; suppl. Fig. S2D ) Ca 2+ buffer Johns et al., 2007 ) O1618 (Fig. 2E) e-aR/GPR55 antagonist (?) 10 Prevented Ca 2+ signaling to AEA Mo et al., 2004; Offertaler et al., 2003 ) Rimonabant (Fig. 2B) CB 1 R and e-aR antagonist 1 Prevented Ca 2+ signaling to AEA Wagner et al., 1999 ) AM251 (Fig. 2C) CB 1 R antagonist 10 Unmasked Ca 2+ signaling to AEA (Fischbach et al., 2007) in Ca 2+ buffer SR144528 (suppl. (Fig. 2H,I , Knockdown of GPR55 Diminished Ca 2+ signaling upon suppl. Fig. S2H ) AEA, O1602, LPI GPR55 (Fig. 2J ,K, Overexpression of GPR55 Enhanced Ca 2+ signaling to AEA, suppl. Fig. S2H ) O1602, LPI of the crosslinking antibody against αvβ3 integrin [LM609, 2 μM (Charo et al., 1990; Cheresh, 1987) ] and two functionblocking antibodies against the β1 [JB1A, 2 μM (Mohri et al., 1996) ] and the β3 subunits [B3A, 2 μM (Vignali et al., 1990) ]. During preincubation for 15 minutes in Ca 2+ -containing medium, none of the integrin-targeting antibodies affected basal endothelial Ca 2+ levels, while all prevented the effect of anandamide in the absence of extracellular Ca 2+ . In line with these findings, B3A also prevented O1602-induced Ca 2+ signaling in Ca 2+ -containing buffer (Fig. 3H ). These data point to the involvement of αvβ3 and α5β1 integrins in GPR55-mediated Ca 2+ signaling by anandamide and O1602 in endothelial cells.
Anandamide induced diverse tyrosine phosphorylation patterns depending on the presence of extracellular Ca
2+
As tyrosine kinases are known to represent early downstream targets of integrin-mediated signaling, the effect of anandamide on the activity of endothelial tyrosine kinases [using the FRET-based sensor Picchu 936X (Kurokawa et al., 2001; Schaeffer et al., 2003) ] and the patterns of tyrosine phosphorylation were assessed in the . Notably, anandamide yielded fast activation of PP1-sensitive tyrosine kinases under any conditions indicated by increase in the FRET signal of Picchu 936X (Fig. 4A ,B) but not the inactive mutant Picchu 938X. Although this is a rather general sensor for several tyrosine kinases and, thus, no conclusion can be drawn on the actual kinase(s) involved, it uniquely reveals the kinetics of tyrosine phosphorylation upon anandamide. However, corresponding western blot analyses revealed markedly different effects of anandamide on protein tyrosine phosphorylation, depending on extracellular Ca Tyrosine phosphorylation upon anandamide in presence and absence of extracellular Ca 2+ was prevented by 10 μM -free solution in the absence (n=25) or presence of the ROCK inhibitor Y27632 (10 μM, n=29). (E-G) The effects of antibodies (2 μM) against αvβ3 integrin (LM609) (control, n=34; LM609, n=30) and the β1 (JB1A) (control, n=28; JB1A, n=33) and β3 subunits (B3A) (control, n=38; B3A, n=30) on cytosolic Ca 2+ signaling induced by 10 μM anandamide was assessed in nominally Ca 2+ -free solution. (H) The effect of function-blocking β3-integrin antibody B3A on O1602 (10 μM) -initiated Ca 2+ signaling in the presence of extracellular Ca 2+ (control, n=65; B3A, n=84). Cytosolic free-Ca 2+ concentrations were recorded using fura-2. *P<0.0001 versus the absence of the respective compound.
4-amine; a potent inhibitor of Src-family tyrosine kinases (Hanke et al., 1996) ] (supplementary material Fig. S4B ), which also abolished anandamide-triggered Ca 2+ signaling in Ca 2+ -free solution (Fig. 4C) , pointing to the activation of Src-family kinase(s) under all conditions. This assumption was further supported by the inhibitory effect of 10 μM PP2 [3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; a potent inhibitor of Src-family tyrosine kinases (Hanke et al., 1996) -containing solution, Ca 2+ intracellular Ca 2+ signaling was initiated by 10 μM O1602 in the presence of 10 μM PP2, followed by an additional stimulation with 10 μM O1602 after washout of PP2 as indicated (n=14). For visualization of tyrosine kinase activity in single endothelial cells, cells were transiently transfected with Picchu 936X. Cytosolic free-Ca 2+ concentration was recorded using fura-2. *P<0.001 versus the absence of PP1. 1H-pyrrole-2,5dione (Bleasdale et al., 1990) , Table 2 ], an inhibitor of PLC (Aschner et al., 1997) was used. Cytosolic Ca 2+ elevations induced by anandamide in the absence of external Ca 2+ (Fig. 5C ) or O1602 in Ca 2+ -containing buffer (Fig. 5D ) were prevented by 2 μM U73122. Moreover, the rather unspecific and membrane permeable Ins(1,4,5)P 3 -receptor antagonist 2APB [2-aminoethoxydiphenylborate (Maruyama et al., 1997; Koganezawa and Shimada, 2002) ] prevented endothelial Ca 2+ elevation in response to 10 μM anandamide and 10 μM histamine at comparable potency with IC 50 values of 43 (30-60) and 87 (50-152) μM, respectively (Fig. 5E ). These data suggest that anandamide-triggered Ca 2+ signaling is due to PLC-mediated formation of Ins(1,4,5)P 3 that, in turn, elevates cytosolic Ca 2+ concentration by intracellular mobilization from the ER.
One potential candidate for bridging PI3K activation to PLC stimulation is bone marrow kinase, X-linked/epithelial and endothelial tyrosine kinase (Bmx/Etk) (Qiu and Kung, 2000) , a member of the Tec family (Takesono et al., 2002) . Immunoprecipitation revealed a 3.2±0.5-fold (n=4) increase in phosphorylation of Bmx/Etk upon anandamide in the absence but not presence of extracellular Ca 2+ (Fig. 6A) -containing solution (Fig. 6B) . Moreover, 10 μM of the selective Tec family inhibitor LFM-A13 [2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide, -containing solution. These data are in line with phosphorylation of the 70-80 kDa band upon anandamide stimulation (supplementary material Fig. S5 ) representing Bmx/Etk that, in turn, activates PLCγ leading to intracellular Ca 2+ mobilization via the generation of Ins(1,4,5)P 3 . Consistent with this, inhibition of Bmx/Etk by 10 μM LFM-A13 also prevented O1602 (10 μM)-triggered Ca 2+ signaling in Ca 2+ containing solution (Fig. 6D ).
In the presence of external Ca 2+ , activation of Syk via Gα i/o exhibited inhibitory action on PI3K-Bmx-PLCγ pathway and prevented anandamide/GPR55-induced Ca 2+ signaling
Based on the western blot (supplementary material Fig. S5 ) that revealed a wortmannin-insensitive tyrosine phosphorylation at 70-80 kDa in the presence but not absence of extracellular Ca 2+ , a negative-feedback mechanism against the PI3K-Bmx-PLCγ signaling via tyrosine phosphorylation [possibly via spleen tyrosine kinase (Syk)] was hypothesized. RT-PCR of the endothelial cell line used proved the expression of Syk in its long form (Wang et al., 2003) (supplementary material Fig. 6B ), which matches the 70-80 kDa band in western blots (supplementary material Fig. S5 ). To further challenge the concept of inhibitory action of Syk on PI3K-Bmx-PLCγ signaling, the effect of the Syk inhibitor piceatannol [3,4,3Ј,5Ј-tetrahydroxy-trans-stilbene (Geahlen and McLaughlin, 1989; Ashikawa et al., 2002) ] was investigated. In cells that only weakly responded to anandamide in the presence of external Ca 2+ , this agonist yielded strong Ca 2+ signaling in the presence of 5 μM piceatannol (Fig. 7A, Table 2 ). These findings were further supported by the induction of Ca 2+ signaling by anandamide despite the presence of extracellular Ca 2+ (Fig. 7B ) in cells, which were transiently transfected with siRNA against Syk (supplementary material Fig. S6A ). To verify the signaling mechanisms by which endothelial CB 1 R triggers activation of Syk, Gα i/o protein, which has been reported to be coupled to this cannabinoid receptor Journal of Cell Science 121 (10) (Mukhopadhyay et al., 2002) , was inhibited by ADP ribosylation with pertussis toxin. Inhibition of Gα i/o protein by pertussis toxin (Table 2) (400 ng/ml, 3 hours) yielded anandamide-induced Ca 2+ signaling even in the presence of extracellular Ca 2+ (Fig. 7C ), thus pointing to Gα i/o -mediated activation of Syk that, in turn, inhibits PI3K-Bmx-PLCγ-Ca 2+ signaling (see Fig. 10 ).
Clustered β1 integrin released binding to CB 1 receptor upon anandamide stimulation
To explore how integrin-clustering shields anandamide-induced PI3K-Bmx-PLCγ-Ca 2+ signaling from the inhibitory effect of CB 1 R-Gα i/o -Syk signaling, interaction of integrins with CB 1 R was investigated by immunoprecipitation. Under conditions of unclustered integrins (i.e. in the presence of external Ca 2+ ), the binding of CB 1 R to β1 integrin was not affected by anandamide (normalized CB 1 R ratio without versus with anandamide 1: 1.03±0.04, n=4, n.s.; Fig.  7D ). By contrast, if integrin clustering was facilitated by Mn 2+ , anandamide yielded detachment of the CB 1 R from β1 integrin (CB1R was normalized to β1 integrin; CB 1 R ratio without anandamide versus -containing buffer was tested. Standard immunoprecipitation was applied. In experiments with siRNA, cells were transiently transfected with a vector encoding approved siRNA against Bmx/Etk. Experiments were performed 48 hours after transfection. Cytosolic free-Ca 2+ concentrations were recorded using fura-2. *P<0.0001 versus the absence of the inhibitor. with anandamide 1: 0.31±0.13, n=4, P<0.05; Fig. 7D ). Identical results were obtained in Ca 2+ -free solution (CB1R was normalized to β1 integrin; CB 1 R ratio without anandamide versus with anandamide 1: 0.30±0.21, n=3, P<0.05; Fig. 7E ). Although under conditions of clustered integrins the binding of the CB 1 R to β1 integrin was affected by anandamide, it did not alter the localization/ distribution of CB 1 R (supplementary material Fig. S6C ).
Thus, under conditions of clustered integrins, anandamide yielded detachment of the CB 1 R from β1 integrin, which, in turn, may preserve anandamide-induced signaling pathways via e-aR leading to cytosolic Ca 2+ elevation.
Depending on integrin clustering, anandamide triggered either nuclear accumulation of NFκB or NFAT while MAPK activation occurred under all conditions
To investigate transcriptional consequences of the two distinct signaling pathways initiated by anandamide via either CB 1 R or eaR, the nuclear recruitment of nuclear factor κB (NFκB) and nuclear factor of activated T-cells (NFAT) upon anandamide stimulation was investigated under conditions of clustered and unclustered integrins. In the presence of extracellular Ca 2+ (i.e. unclustered integrins), anandamide evoked nuclear accumulation of the p65 subunit of NFκB (Fig. 8A ) but not NFAT (Fig. 9A) , whereas if integrins were clustered by Mn 2+ in the presence of external Ca 2+ , anandamide failed to stimulate p65 translocation (Fig. 8B ) but evoked strong nuclear accumulation of NFAT (Fig.  9B) .
In contrast to the selective activation of the transcription factors NFκB and NFAT, Erk1 and Erk2 were activated by anandamide under all circumstances. Notably, Erk1 and Erk2 activation in response to anandamide was slightly faster (+42±26% after 2 minutes) but less pronounced (maxima +430±88% after 45 minutes; n=3) under conditions of unclustered integrins (Fig. 9C) ). Right panels shows precipitation with beads that were not preloaded with anti-β1-integrin were used. (E) Immunoprecipitation using anti-β1-integrin antibody and subsequent staining with either anti-β1-integrin (upper blot), anti-αV-integrin (middle blot) or anti-CB 1 R (lower blot). Endothelial extracts were harvested from cells under basal conditions (-) and after stimulation with 10 μM anandamide (+) in the and absence (EGTA) of extracellular Ca 2+ . Right panels shows precipitation with beads that were not preloaded with anti-β1-integrin were used. Standard immunoprecipitation was applied. In experiments with siRNA, cells were transiently transfected with a vector encoding approved siRNA against Syk 48 hours prior to the experiments. Cytosolic free-Ca 2+ concentrations were recorded using fura-2. *P<0.0001 versus the absence of the inhibitor. and maxima +730±185% after 45 minutes; n=3) (Fig. 9D ) or in the absence of extracellular Ca 2+ (data not shown).
Discussion
Our data demonstrate that two distinct receptors for anandamide exist in human endothelial cells, which were characterized as CB 1 R and GPR55. Both receptors trigger distinct signaling pathways, whereby one exhibits negative feedback on the other, depending on the status of integrin configuration. As illustrated in Fig. 10A , the presence of extracellular Ca 2+ anandamide binding to CB 1 R results in G i protein-mediated activation of Syk and its subsequent signal transduction pathway, resulting in activation of NFκB. Additionally, Syk inhibits PI3K that represents a key signaling protein in the transduction of GPR55-originated signaling. However, once integrins are clustered (Fig. 10B) , Syk does not further inhibit GPR55-triggered signaling. Subsequently, the latter causes intracellular Ca 2+ mobilization from the ER via a PI3K-Bmx-PLCγ pathway and, in turn, activation of Ca 2+ -activated NFAT (Fig. 10B) . Notably, although the activation of transcription factors varies depending on the signaling pathway, Erk1 and Erk2 are activated Journal of Cell Science 121 (10) under all circumstances (Fig. 10) . Although the physiological consequences of these concomitant and interrelated signaling pathways in response to anandamide in endothelial cells are unclear and need to be further explored, the crucial role of integrin-clustering may point to a circumstance-dependent bivalent contribution of this endocannabinoid to cell stimulation, proliferation, angiogenesis and/or migration under conditions such like inflammation, permeability or hypoxia.
Receptor(s) involved in anandamide-induced endothelial cell activation
Endocannabinoids interact with two cannabinoid receptors identified by molecular cloning: CB 1 R, which is expressed predominantly in the brain (Matsuda et al., 1990) but is also present in peripheral tissues (Shire et al., 1995) , and CB 2 R, expressed mainly by cells of the immune system (Munro et al., 1993) but also calf pulmonary aortic endothelial cells . In human and murine vasculature, the actions of endogenous cannabinoids have been widely interpreted as being mediated by CB 1 R, although there is a . Images of endothelial cells that were transiently transfected with p65-GFP were taken 48 hours after transfection using a conventional fluorescence microscope. Representative images of at least 10 cells out of three experiments on alternate days are shown. Scale bars: 10 μm. . Images of endothelial cells that were transiently transfected with NFAT-GFP were taken 48 hours after transfection using a conventional fluorescence microscope. Data presented are representative for at least eight cells out of three experiments on alternate days. Scale bars: 10 μm. For assessment of Erk1 and Erk2 activation, standard western blotting was applied.
growing amount of evidence, particularly in isolated heart and blood vessel preparations, that another cannabinoid receptor, referred as e-aR may exist (Offertaler et al., 2003) .
Our findings that, despite the presence of CB 1 R, its very selective synthetic agonist HU210 [(6aR)-trans-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1hydroxy-6,6-dimethyl- (Felder et al., 1995) failed to stimulate intracellular Ca 2+ signaling while the e-aR agonist O1602 (Bukoski et al., 2002; Jarai et al., 1999 ) evoked a strong Ca 2+ signal in Ca 2+ containing solution, indicate that anandamidetriggered Ca 2+ signaling is mediated by e-aR in the human umbilical vein-derived endothelial cell line used in this study. However, anandamide failed to induce a Ca 2+ signal in the presence of extracellular Ca 2+ . Accordingly, this points to a repressive effect of CB 1 R-originated signal transduction on signaling pathways beyond e-aR. This hypothesis was further confirmed by our findings that activation of CB 1 R with HU210 strongly diminished the O1602-initiated Ca 2+ signal. Notably, caution is advised on the specificity of CBR antagonist/agonists, and, thus, additional efforts to characterize involved receptors were undertaken.
However, in the absence of external Ca 2+ , anandamide initiated strong cytosolic Ca 2+ signaling. Notably, this signal was insensitive to the CB 2 R antagonist SR144528 but was prevented by rimonabant, an inhibitor of CB 1 R as well as of e-aR (Offertaler et al., 2003) . Importantly, as O1918, the antagonist of the e-aR Mo et al., 2004; Offertaler et al., 2003) , prevented anandamideinduced Ca 2+ signaling in the absence of external Ca
2+
, these data indicate that in the nominal absence of extracellular Ca 2+ the CB 1 Roriginated suppressive effect is uncoupled from the e-aR pathway, and, thus, allows the generation of a Ca 2+ signal. Hence, using RT-PCR and siRNA, the putative anandamide receptor GPR55 (Brown, 2007; Hiley and Kaup, 2007; Ryberg et al., 2007) was identified as the e-aR. Hence, overexpression of GPR55 strongly increased Ca 2+ signaling upon anandamide and O1602 treatment in Ca
-free and Ca 2+ -containing buffer, respectively. However, the potency of anandamide was less in this study than previously reported (Ryberg et al., 2007) , which may be due to the different cell models (i.e. transfected HEK 293 cells versus endothelial cells). Hence, lysophosphatidylinositol, a recently described agonist of the GPR55 (Oka et al., 2007) , was found to trigger Ca 2+ signaling via constitutive GPR55 in endothelial cells. Accordingly, there are several questions arising: first, how does the e-aR/GPR55 trigger Ca 2+ signaling; second, what is the molecular mechanism of the CB 1 R-mediated suppressive effect on anandamide-induced Ca 2+ signaling; third, why and how is the Ca 2+ signal via e-aR/GPR55 shielded from CB 1 R-mediated suppression in the absence of extracellular Ca 2+ ; and, fourth, what are the physiological consequences of both signaling pathways for transcriptional control in endothelial cells?
GPR55 interacts with integrins and triggers Ca 2+ signaling via PI3K and Bmx
In the absence of extracellular Ca 2+ , integrins might be involved in the transition of GPR55-originated signaling that yields intracellular Ca 2+ mobilization from the ER (Fig. 10B) . In particular, the inhibitory properties of the crosslinking antibody against αvβ3 integrin [LM609 (Charo et al., 1990; Cheresh, 1987) ] and the functional-blocking antibodies against the β1 [JB1A (Mohri et al., 1996) ] and β3 subunits [B3A (Vignali et al., 1990) ] on anandamide/ O1602-induced Ca 2+ signaling fuel the hypothesis that, upon anandamide/O1602 stimulation, GPR55 interacts with αvβ3 and α5β1 integrins, which is prerequisite to transmitting outside-in signaling towards intracellular downstream targets (Fig. 10A ). This conclusion is further supported by the inhibitory effects of fibronectin (Rupp and Little, 2001) or its integrin-binding motif RGD (Bar-Shavit et al., 1991; Ruoslahti, 2003; Ruoslahti and Pierschbacher, 1987) on anandamide-/O1602-induced Ca 2+ signaling. The importance of integrin clustering was additionally confirmed by our results that the inhibition of ROCK, which is required for clustering of the integrins (Rodriguez-Fernandez et al., 2001) , by Y27632 (Uehata et al., 1997) -free medium was sensitive to the inhibition of PI3K, PLC and the Ins(1,4,5)P 3 receptor. Thus, the involvement of PI3K upstream of PLC activation and Ins(1,4,5)P 3 -mediated intracellular Ca 2+ mobilization can be assumed (Fig. 10B) . The 70-80 kDa protein Bmx/Etk, a unique tyrosine kinase of the Tec family in endothelial and epithelial cells (Takesono et al., 2002) , was identified as mediator between PI3K and PLC. PI3K-induced activation of Bmx/Etk has been described in prostate cancer cells and in breast cancer cells (Bagheri-Yarmand 2+ signaling under conditions of unclustered integrins originates from CB 1 R that is linked to β1 integrin and stimulates Syk via Gα i/o , subsequently resulting in the activation of NFκB, Erk1 and Erk2. Additionally, Syk inhibits PI3K and, thus, the downstream signaling of the GPR55 is prevented. (B) Once integrins are clustered, CB 1 R uncouples from β1 integrin and, thus, no negative feedback on PI3K via Syk occurs. Consequently, GPR55-initiated signaling becomes promoted, resulting in the activation of a PI3K-Bmx-PLCγ cascade that triggers in the production of IP 3 and subsequent intracellular Ca 2+ mobilization, yielding activation of NFAT, Erk1 and Erk2. Based on the data presented, involvement of G q/s in GPR55-triggered signaling cannot be not confirmed or excluded at this stage. Abbreviations: α1β3, α1β3 integrin; αvα5, αvα5 integrin; Bmx/Etk, bone marrow kinase, X-linked/epithelial and endothelial tyrosine kinase; CB 1 R, cannabinoid 1 receptor; ER, endoplasmic reticulum; Erk1/2, extracellular signal regulated kinases 1 and 2; GPR55, G-protein-coupled receptor 55 (e-aR, 'atypical' endothelial anandamide receptor); IP 3 , Ins(1,4,5)P 3 ; G i , G i protein; G q , G q (G α13 ) protein; NFAT, nuclear factor of activated T-cells; NFκB, nuclear factor κB; p50, nuclear factor κB p50; p65, nuclear factor κB, subunit 3; PI3K, phosphoinositide 3-kinase; PLC, phospholipase C; Syk, spleen tyrosine kinase; Tk, tyrosine kinase. Qiu et al., 1998) . In support of this, the Tec family inhibitor LFM-A13 (Chau et al., 2002; Mahajan et al., 1999) , as well as Bmx/Etk-targeted siRNA inhibited anandamide-and O1602-induced Ca 2+ signaling. Our data that the wide-range tyrosine kinase inhibitors PP1 and PP2 (Liu et al., 1999) abolished anandamideand O1602-induced Ca 2+ signaling, and the enhanced tyrosine phosphorylation lead us to suggest that Bmx/Etk undergoes tyrosine phosphorylation by Src family kinases.
Overall, our data point to anandamide-triggered Ca 2+ signaling as the apparent result of a signaling cascade starting with anandamide binding to GPR55 that clusters with αvβ3 and α5β1 integrins to transmit outside-in signaling, leading to PI3K-mediated activation/translocation of Bmx/Etk. After Bmx/Etk phosphorylation by a member of the Src family (Stephens et al., 2001) , it activates PLCγ (Qin and Chock, 2001 ) that, in turn, instigates Ins(1,4,5)P 3 -triggered intracellular Ca 2+ mobilization from the ER (Fig. 10B) , pointing to the involvement of Gα i/o downstream of CB 1 R in a negative-feedback loop that prevents intracellular Ca 2+ signaling upon anandamide under these conditions (Fig. 10A) .
A potential executor of the inhibitory effects on GPR55-PI3K-Bmx signaling downstream of CB 1 R and Gα i/o is Syk. This tyrosine kinase with splicing variants of ~72 kDa and ~68 kDa (Wang et al., 2003) inhibits activation of PI3K in breast cancer cells and is expressed in endothelial cells (Inatome et al., 2001) . Accordingly, the long form of Syk could be found in the human endothelial cell line used for this study. Moreover, selective inhibition of Syk by piceatannol (Ashikawa et al., 2002) and the respective siRNA unmasked anandamide-triggered Ca 2+ signaling in the presence of extracellular Ca
2+
. Additionally, wortmannin-resistant tyrosine phosphorylation of a 70-80 kDa protein was found in response to anandamide in the presence but not absence of extracellular Ca 2+ . These data indicate that endothelial Syk indeed executes repression of anandamide-triggered Ca 2+ signaling downstream to CB 1 R and Gα i/o (Fig. 10A) .
Integrins shield GPR55-triggered signaling from CB 1 Rcontrolled suppression -induced inhibition of integrin clustering (Leitinger et al., 2000; Leitinger et al., 1999) . Consequently, the involvement of these dynamically regulated transmembrane heteromultimers in unmasking GPR55-triggered Ca 2+ signaling in the absence of extracellular Ca 2+ was postulated.
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Clustered integrins (i.e. in the absence of extracellular Ca
2+
) may protect GPR55-initiated signaling against the repressive effects of CB 1 R-originated pathways. In line with this assumption, Mn 2+ , a potent activator of integrin clustering (Mould et al., 1998; Smith and Cheresh, 1990; Thamilselvan et al., 2003) , allowed anandamideinduced Ca 2+ signaling even in the presence of extracellular Ca 2+ , while Mn 2+ did not induce any Ca 2+ signal by itself. In addition, binding of CB 1 R to the β1-integrin subunit was released upon anandamide only if integrins were clustered, which further supports the concept that clustering of integrins shields anandamide-induced PI3K-Bmx-PLCγ-Ca 2+ signaling from the inhibitory effect of CB 1 R activation (Fig. 10) . Besides CB 1 R, phospho-Syk was also found to interact directly with the cytoplasmic domain of β1-, β2-and β3-integrin subunits (Woodside et al., 2002) .
Accordingly, the interaction of CB 1 R and Syk with inactive (i.e. unclustered) β1 integrin might either disturb the cytoplasmic integrin rearrangement necessary to transmit the GPR55-initiated signal to its downstream target or allow Syk-mediated inhibition of PI3K owing to the proximity of both proteins (Fig. 10A) . However, once integrins cluster either by activation of ROCK, extracellular Mn 2+ or removal of extracellular Ca
, CB 1 R and Syk are released from β1 integrin and no further suppression of PI3K occurs, thus allowing GPR55-originated Ca 2+ signaling to be transmitted (Fig. 10B) . Though the involvement of a G α13 in GPR55-triggered Ca 2+ signaling (Ryberg et al., 2007) seem unlikely in the cells used, owing to the involvement of integrins, it cannot be excluded.
In contrast to anandamide that binds to CB 1 R and GPR55, activation of GPR55 only by either O1602 or LPI yielded Ca , thus indicating that the negative feedback by CB 1 R needs to be activated in order to achieve inhibition of the GPR55-originated pathway.
Transcription factor activation upon anandamide depends on the signaling pathway activated Syk induces tyrosine phosphorylation of IκBα, causing dissociation, phosphorylation and nuclear translocation of the p65 subunit of NFκB (Takada et al., 2003) . This is in line with the data indicating that, in the presence of extracellular Ca 2+ , anandamide triggered nuclear translocation of p65 (Fig. 10A) . However, under conditions of clustered integrins, anandamide failed to evoke the translocation of p65. The lack of NFκB activation under these conditions is consistent with reports pointing to the importance of Ca 2+ oscillation for the activation of this transcription factor (Hu et al., 1999) . By contrast, nuclear translocation of Ca 2+ /calcineurin activated NFAT (Clipstone and Crabtree, 1992; Loh et al., 1996) upon stimulation with anandamide was exclusively obtained under conditions of clustered integrins (Fig. 10B) . These findings are in agreement with our previous report that intracellular Ca 2+ mobilization activates NFAT in human endothelial cells (Bochkov et al., 2002) . Notably, although the contribution of NFκB and NFAT to gene expression and regulation of cell function often overlaps, there are considerable differences as NFκB is frequently referred to as being involved in endothelial cell apoptosis (von Albertini et al., 1998) and the initiation of inflammatory processes (Badrichani et al., 1999) , while NFAT has been implicated in angiogenesis (Qin et al., 2006) and cell growth (Li et al., 2005) .
Interestingly, anandamide-activated mitogenic signaling results in phosphorylation of Erk1 and Erk2 under all conditions, which is consistent with frequent reports that integrins and cannabinoid receptors induce mitogen-activated protein kinase (MAPK) signaling pathways (Liu et al., 2000) . The phenomenon of Erk1 and Erk2 phosphorylation under the various conditions (i.e. with and without Ca 2+ signaling) might be related to the activation of different pathways, resulting in phosphorylation of Erk1 and Erk2. Consistently, Syk stimulates Erk1 and Erk2 via the Ras-MAPK pathway (Kawakami et al., 2003) but also Ca 2+ that is known to influence cell proliferation and differentiation (Berridge et al., 2000a; Berridge et al., 2000b) stimulates the Ras-MAPK pathway (Cullen and Lockyer, 2002) .
In addition to such alternative activation of distinct transcription factors, the observed GPR55-triggered Ca 2+ signaling may also mediate Ca 2+ -sensitive cell functions such as activation of nitric oxide synthase, formation of prostaglandins or endothelium-derived hyperpolarizing factor (Graier et al., 1994) , proliferation (Munaron, 2002) , or permeability (Tiruppathi et al., 2006) . Accordingly, depending on the status of integrins, anandamide initiates alternate processes in endothelial cells that may even lead to opposite cell functions (e.g. apoptosis versus cell proliferation).
Although both signaling cascades and their mutual interrelation could be described in herein, important questions still remain to be answered. What are the events that favor one of the two alternative signaling pathways? What are the physiological and/or pathological consequences of the respective signaling cascades? Particularly in view of the known initiators of integrin clustering such as inflammation (Staunton et al., 2006) , adhesion (Shattil and Newman, 2004) and migration (Lindbom and Werr, 2002) , the physiological implication of the dual signaling induced by anandamide in endothelial cells urges its investigation.
Materials and Methods

Chemicals, supplies and materials
Fura-2/AM was from Molecular Probes Europe (Leiden, Netherlands). 3 H-anandamide was obtained from APB (Vienna, Austria). Anandamide (arachidonylethanolamide), R-(+)-methandamide, U73122, 2APB, LMF-A13, HU210 and piceatannol were purchased from Tocris Cookson (Northpoint, Avonmouth, Bristol, UK). O1602, O1918 and AM251 were from Cayman Europe (Tallinn, Estonia). SR144528 and rimonabant were kind gifts from Sanofi-Recherche (Monpellier, France). Bradykinin, arachidonic acid, ATP and lysophosphatidylinositol were from Sigma Chemicals (St Louis, MO, USA). RNeasy Mini kit and the EndoFree Plasmid Maxi kit were purchased from Qiagen (VWR, Vienna, Austria). RQ1 RNase-free DNase I and TransFas were from Promega (Mannheim, Germany). RNAguard and random hexamer primers were from APB. First-strand buffer, moloney murine leukemia virus reverse transcriptase, cell culture media and media substitutes were obtained from Life Technologies (Gibco, Invitrogen, Vienna, Austria). Fetal calf serum was from PAA (Linz, Austria). DyNAzyme II DNA polymerase was from Finnzymes Oy (Vienna, Austria). Primers were synthesized at MWG Biotech (Ebersberg, Germany). Restriction enzymes and T4 DNA ligase were purchased at New England BioLabs (Frankfurt, Germany) or Promega. The expression vectors pcDNA 3 and pBudCE4.1 were obtained from Invitrogen (Vienna, Austria). The dNTPs and all other chemicals were from Roth (Karlsruhe, Germany). The CB1R antibody (H-150) was from Santa Cruz Biotechnology (Heidelberg, Germany). Antibodies for β1 integrin (JB1A) and αV integrin (SAM-1) were obtained from Biomedica/Chemicon (Millipore, Vienna, Austria) and Protein G Sepharose 4 Fast Flow for immunoprecipitation was from GE Healthcare (Vienna, Austria).
Cell culture and transfection
The human umbilical vein derived endothelial cell line, EA.hy926 (Edgell et al., 1983) at over 45 passages was grown in DMEM containing 10% FCS and 1% HAT. In addition, we have performed experiments in short-term cultured human umbilical vein endothelial cells and human uterine artery endothelial cells (Trenker et al., 2007) . If necessary, dishes were coated with 20 μg/ml fibronectin (Short et al., 1998) . Transient transfection was performed using Transfast according to the manufacturer's protocol.
Reverse transcriptase-PCR
Total RNA was isolated using the RNeasy Mini Kit according to the manufacturer's protocol and subjected to RT-PCR as described previously . The identity of all PCR products was verified on TAE agarose gels and was further confirmed by automated sequencing of the isolated PCR.
Reduction of gene expression by siRNA
The siRNA against human Bmx/Etk was selected at position 1482 bp of the human mRNA and ligated into pSuppressor using the SalI/XbaI sites. For identification of siRNA-expressing cells, the U6 promotor and Bmx/Etk or Syk siRNA were cloned into pBudCE4.1 encoding mtDsRed via KpnI/XhoI at the second multicloning site. The siRNA against human Syk in pSuppressor was purchased by Imgenex. siRNA against GPR55 was from Quiagen (Hs_GPR55_5_HP). The efficiency of siRNAs and of an appropriate negative control was approved by realtime PCR (supplementary material Fig. S2E; see Fig. 4A ).
Western blot analysis
EA.hy926 cells were scraped in lysis buffer and disrupted by three cycles of freezing/thawing. Equal amounts of total protein were subjected to western blot and detected by enhanced chemiluminescence as previously described (Schaeffer et al., 2003) . If required, membranes were stripped with 0.1 M glycine (pH 2.5), and reprobed.
Immunoprecipitation
Cell lysates were incubated with 2-5 μg (200 μg/ml) of specific antibody overnight. The obtained immune complexes were precipitated with Protein G Sepharose 4 Fast Flow, according to the manufacturer's protocol and subjected to western blot analyses.
Immunohistochemistry
Fixed and permeabilized cells grown on glass cover were incubated overnight at 4°C with anti-NFAT antibody. After incubation with Alexa Fluor 488 secondary antibody (2 μg/ml), the glass cover slips were sealed and fluorescence was visualized using deconvolution microscopy.
Measurement of tyrosine kinase activity
Tyrosine kinase activity was monitored in single endothelial cells using a probe for tyrosine phosphorylation of the CrkII adaptor protein [Picchu-936X (Kurokawa et al., 2001 )], as previously described (Schaeffer et al., 2003) .
Cytosolic free Ca 2+ measurements
Cytosolic free-Ca 2+ was measured using Fura2/AM as previously described (Frieden et al., 2002; Malli et al., 2005; Trenker et al., 2007) . [Ca 2+ ] cyto was expressed as (F 340 /F 380 )/F 0 .
FRET measurement of endoplasmic free-Ca 2+ concentration and kinase activity Tyrosine kinase activity was monitored in single endothelial cells using a probe for tyrosine phosphorylation of the CrkII adaptor protein [Picchu-936X (Kurokawa et al., 2001) ] as previously described (Schaeffer et al., 2003) . For the assessment of the intraluminal free-Ca 2+ concentration of the ER, cells were transiently transfected with Cam4 er and measurements were performed as described previously (Frieden et al., 2002; Malli et al., 2003; Malli et al., 2005) . FRET-based sensors were excited at 440 nm (440AF21, Omega Optical, Brattleboro, VT, USA) and emission was collected simultaneously at 535 and 480 nm using an optical beam splitter (Dual-View MicroImager, Optical Insights, Visitron Systems, Puchheim, Germany). Kinase activity or alterations in ER Ca 2+ were expressed as (F 535 /F 480 )/F 0 .
